INTRODUCTION
Naive CD4 + T cells differentiate into at least four types of T helper (Th) cells, including Th1 cells, Th2 cells, inducible T regulatory cells and Th17 cells. Th1 cells produce cytokines, such as IFNg and lymphotoxin alpha, and activate macrophages and CD8 + T cells to induce immunity against intracellular pathogens, whereas Th2 cells produce signature cytokines, interleukin-4 (IL-4), IL-5, IL-9, and IL-13, that are involved in host defense against extracellular pathogens such as helminths (Ansel et al., 2006; Murphy and Reiner, 2002; Zhu and Paul, 2008) . Differentiation fate is determined by several factors, including the nature and dose of antigen, the type of costimulation, and the cytokine milieu.
Both IFN-g and IL-12 play important roles in Th1 differentiation. The capacity of T cells to produce IFN-g is programmed by various transcription factors, including STAT4, two T-box protein family members, T-bet and Eomesodermin (Eomes), and Runx3. STAT4 is activated by IL-12; STAT4-deficient CD4 + T cells have a defect in IFN-g production (Jacobson et al., 1995; Kaplan et al., 1996; Thierfelder et al., 1996; Watford et al., 2004) . T-bet is induced mainly through an IFN-g-STAT1dependent pathway (Afkarian et al., 2002; Lighvani et al., 2001) , but the IL-12-STAT4 pathway also contributes to T-bet upregulation (Yang et al., 2007) . T-bet not only promotes Th1 cell differentiation but also represses Th2 cell differentiation by suppressing GATA3 expression (Usui et al., 2006) and reducing the binding of GATA3 to DNA (Hwang et al., 2005; Szabo et al., 2000) . T-bet-deficient (Tbx21 À/À ) ''Th1'' cells and Tbx21 À/À NK cells produce less IFN-g than do wild-type (WT) cells. Although T-bet deficiency does not affect IFN-g production by CD8 + T cells in vitro , it results in reduced numbers of IFN-g-producing antigen-specific CD8 + T cells in response to LCMV infection (Intlekofer et al., 2007; Joshi et al., 2007) . Pearce et al. (2003) reported that IFN-g production by Tbx21 À/À CD8 + T cells in vitro was dependent on the expression of Eomes.
Runx3, a critical transcription factor for silencing CD4 expression during T cell development (Taniuchi et al., 2002) , has been reported to be expressed at higher amount in Th1 cells than in Th2 cells (Djuretic et al., 2007; Naoe et al., 2007) . Runx3 enhances IFN-g production, although the detailed mechanism through which it does so is not clear (Djuretic et al., 2007) . In addition, Runx3 has been reported to directly repress IL-4 transcription by binding, in collaboration with T-bet, to the DNase I hypersensitivity (HS) IV region of the Il4 gene (Djuretic et al., 2007) . Runx3 fl/fl -CD4-Cre mice spontaneously show an asthmalike phenotype, including increased serum IgE and infiltration of lymphoid cells in the lung and bronchoaveolar lavage fluid, implying that Runx3 is also important for repressing Th2 responses .
IL-4 and IL-2 are indispensable for in vitro Th2 differentiation (Cote-Sierra et al., 2004; Yamane et al., 2005; Zhu et al., 2003) . The regulation of Th2 differentiation and of the capacity of these cells to produce Th2 cytokines depends on several transcription factors, including STAT5, STAT6, and GATA3 (Zhu et al., 2006) . GATA3, the ''master'' transcription factor for Th2 differentiation, is upregulated both by TCR stimulation and IL-4-STAT6 signaling (Ouyang et al., 1998; Zheng and Flavell, 1997) . By contrast, GATA3 expression is diminished during Th1 differentiation. Enforced GATA3 expression in developing Th1 cells induces IL-4-producing capacity. The importance of GATA3 expression during Th2 differentiation, both in vitro and in vivo, has been confirmed utilizing GATA3-conditionally-deficient mice (Pai et al., 2004; Zhu et al., 2004) . These experiments showed that GATA3 is critical for promoting Th2 cell expansion, as well as for Th2 cell differentiation.
GATA3 also negatively regulates Th1 differentiation. It represses IFN-g production through an IL-4-independent pathway (Ouyang et al., 1998; Usui et al., 2003) . Ouyang et al. (1998) showed that overexpression of GATA3 in Th1 cells inhibited IL-12Rb2 expression, which is normally induced under Th1 conditions. However, enforced IL-12Rb2 expression in GATA3overexpressing Th1 cells does not restore IFN-g production, implying that another mechanism, possibly downregulation of STAT4, contributes to GATA3 repression of Th1 differentiation (Usui et al., 2003) .
Interestingly, GATA3-deficient CD4 + T cells cultured under Th2 conditions produced IFN-g, indicating that endogenous GATA3 is required to actively repress IFN-g production in Th2 cells and that without GATA3, IFN-g production can be induced in the absence of the two established Th1-inducing factors, IL-12 and IFN-g (Pai et al., 2004; Zhu et al., 2004) . Furthermore, in GATA3-conditionally-deficient mice, CD4 + T cells produced IFN-g in response to Nippostrongylus brasiliensis infection, an infection that elicits strong Th2 responses in WT mice. We were intrigued by this finding and became interested in understanding how GATA3 mediated IFN-g repression. Here, we show that GATA3 suppresses both STAT4-and T-bet-independent Eomes expression and IFN-g production. Our results indicate that the ratio of Runx3 to GATA3 determines the degree of IFN-g expression. This ''balanced'' regulation may be explained by the capacity of GATA3 and Runx3 to bind to each other. Furthermore, we show that Runx3 binds to many critical regulatory elements of Ifng gene, some of which colocalize with T-bet binding sites, suggesting that Runx3 directly regulates IFN-g production.
RESULTS
Deletion of Gata3 Allows IFN-g Production Independently of IL-12-STAT4 and IFN-g-T-bet GATA3 is important for CD4 + T cell development in the thymus and for Th2 cell differentiation in the periphery (Ho et al., 2009 ). To investigate the role of GATA3 in T cells at different developmental stages, we generated mice in which exon4 of Gata3 is flanked by two loxP sites (Gata3 fl/fl ). Gata3 deletion by CD4-Cre greatly diminished the development of CD4 + T cells. Of the few peripheral CD4 + T cells that do appear in such mice, the majority displayed a memory phenotype . We also reported that deletion of Gata3 by OX40-Cre in activated T cells abolished Th2 responses to Nippostrongylus brasiliensis infection and allowed the production of IFN-g by cells from infected mice. However, the effect of Gata3 deletion in naive CD4 + T cells has not been previously tested. The expression of humanized Cre driven by the distal Lck promoter (dLck-Cre Tg, line 3779) efficiently deletes floxed genes in CD4 or CD8 single-positive T cells in the thymus and naive CD4 + T cells in the periphery (Zhang et al., 2005) . To investigate the function of GATA3 in naive CD4 + T cells, Gata3 fl/fl -dLck-Cre mice were prepared by crossing Gata3 fl/fl mice to dLck-Cre Tg mice.
CD4 + and CD8 + T cells developed normally in the thymi of Gata3 fl/fl -dLck-Cre mice and the majority of CD4 + and CD8 + T cells in periphery of these mice displayed a naive phenotype (CD62L hi CD44 lo ), in a percentage that was indistinguishable from that of control mice ( Figure S1A available online). The deletion efficiency of the Gata3 gene in CD4 + and CD8 + T cells from Gata3 fl/fl -dLck-Cre mice was approximately 70% and 90%, respectively ( Figure S1B ). Thus, unlike Gata3 fl/fl -CD4-Cre mice in which GATA3-deficient naive CD4 + T cells were not present in substantial numbers because the gene was deleted too early during T cell development, Gata3 fl/fl -dLck-Cre mice provide a unique opportunity to study the role of GATA3 at early stages of T cell differentiation from naive CD4 + T cells.
Naive CD4 + T cells were isolated from Gata3 fl/fl -dLck-Cre or Gata3 fl/fl mice and then cultured with soluble anti-CD3 and anti-CD28 in the presence of T-depleted splenocytes under Th1 (IL-12 and anti-IL-4) or Th2 conditions (anti-IL-12, anti-IFN-g, and IL-4). Gata3 deletion in Th1 cells did not affect IFN-g production by these cells ( Figure 1A , left panel). As expected, IL-4 production by these Gata3 fl/fl -dLck-Cre ''Th2'' cells upon stimulation was dramatically lower than that by controls (31.2% versus 69.9%, Figure 1A , middle panel). IFN-g production was induced in $24% of the ''Th2'' cells from Gata3 fl/fl -dLck-Cre mice even though both IL-12 and IFN-g were neutralized in the culture. Because the deletion of Gata3 by dLck-Cre is incomplete, intracellular staining of GATA3 was carried out to identify the Gata3-deleted cells ( Figure 1A , right panel). Among the Gata3 fl/fl -dLck-Cre ''Th2'' cells, IL-4 was produced only by CD4 + T cells from which GATA3 had not been deleted, whereas IFN-g was produced mainly by CD4 + T cells that had deleted the gene. A substantial amount of IFN-g was detected by ELISA in the supernatant of Gata3 fl/fl -dLck-Cre ''Th2'' cells ( Figure 1B ). Careful kinetic study showed that IFN-g expression by Gata3 fl/fl -dLck-Cre cells cultured under Th2 conditions, similar to that by WT Th1 cells, was most prominent at 48 hr after stimulation (data not shown). These data imply that GATA3 is crucial for the induction of IL-4 production and that loss of GATA3 in naive CD4 + T cells allows IFN-g production when they become activated in the absence of engagement of both the IL-12-STAT4 pathway and the IFN-g-STAT1 pathway.
T-bet is the ''master regulator'' of IFN-g production in Th1 cells (Szabo et al., 2000) . To test whether T-bet is involved in the IFN-g production in GATA3-deficient ''Th2'' cells, we generated Gata3 fl/fl -dLck-Cre-Tbx21 À/À mice deficient in both GATA3 and T-bet. Whereas $15% of Tbx21 À/À Th1 cells produced IFN-g, $67% of Gata3 fl/fl -dLck-Cre-Tbx21 À/À Th1 cells did so (Figure 1C, left panel) . Identical to the data shown in Figure 1A , more than 90% of Gata3 fl/fl and Gata3 fl/fl -dLck-Cre Th1 cells in this experiment produced IFN-g (data not shown). Importantly, $25% of Gata3 fl/fl -dLck-Cre-Tbx21 À/À cells cultured under Th2 or neutral conditions (without addition of exogenous cytokines and antibodies to cytokines) produced IFN-g ( Figure 1C , middle and right panels). Tbx21 À/À and Gata3 fl/fl -dLck-Cre-Tbx21 À/À were also infected with Nippostrongylus brasiliensis. IL-4 and IFN-g mRNA were measured by quantitative PCR on day 9 after infection ( Figure 1D ). IL-4 expression was dramatically reduced, and IFN-g expression was enhanced in Gata3 fl/fl -dLck-Cre-Tbx21 À/À cells compared to Tbx21 À/À cells. These data indicate that GATA3 regulates T-bet-independent IFN-g production both in vitro and in vivo.
Eomes, but Not T-bet, Is Upregulated in Gata3 fl/fl -dLck-Cre ''Th2'' Cells To determine how deletion of GATA3 allowed IL-12-IFN-g-independent IFNg production in CD4 + T cells, the expression of the IFNg-inducing transcriptional factors T-bet, Eomes, Runx3, and STAT4 was assessed by quantitative PCR in both WT and GATA3-deficient ''Th2'' cells ( Figure 2A ). Strikingly, Eomes, but not T-bet, mRNA was increased in GATA3-deficient ''Th2'' cells. Intracellular staining of Eomes and T-bet confirmed that GATA3deficient ''Th2'' cells expressed Eomes, but not T-bet (Figure 2B) . Virtually all the cells that had deleted GATA3 from Gata3 fl/fl -dLck-Cre ''Th2'' group expressed Eomes, although only a small proportion of WT Th1 cells expressed this transcription factor. Furthermore, GATA3-deficient Th1 cells failed to express Eomes, suggesting that either Th1 factors inhibit Eomes expression or IL-4 induces Eomes when GATA3 is absent. STAT4 was also upregulated in Gata3 fl/fl -dLck-Cre ''Th2'' cells at both mRNA ( Figure 2A ) and protein amounts ( Figure 2C ), consistent with the previous report that GATA3 suppresses STAT4 expression in Th2 cells (Usui et al., 2003) . Runx3 was slightly increased at both mRNA and protein levels when Gata3 was deleted from differentiating Th2 cells; however, such Runx3 expression is still much lower than its expression in Th1 cells. Thus, the loss of GATA3 during Th2 differentiation results in increased expression of Eomes and STAT4, but not T-bet.
Th1 cells also preferentially express IL-12Rb2 and CXCR3. In GATA3-deficient ''Th2'' cells, the expression of IL-12Rb2 was slightly enhanced, while CXCR3 expression was dramatically upregulated ( Figure S2 ). Upregulation of STAT4 expression and a slight increase of IL-12Rb2 could contribute to IFN-g production if IL-12 were present; however, IL-12 is not available in the Th2 cultures and we failed to detect STAT4 phosphorylation in After cultured with IL-2-containing medium for another 2 days, the cells were restimulated with PMA plus ionomycin for 4 hr. The expression of IL-4, IFN-g, and GATA3 were measured by intracellular staining. Numbers indicate the percentage in each quadrant. (B) The amount of IFN-g protein in the supernatants of the cells prepared in (A) that had been restimulated with PMA and ionomycin for 24 hr was measured by ELISA. Error bars represent means ± SD. (C) Naive CD4 + T cells isolated from Tbx21 À/À or Gata3 fl/fl -dLck-Cre-Tbx21 À/À mice were activated under Th1, Th2, or ThNeutral conditions and analyzed as in (A). (D) Nine days after N. brasiliensis infection, CD44 hi CD62L lo CD4 + T cells were sorted from mesenteric lymph nodes of the infected mice and quantitative RT-PCR was performed. The relative expression of IL-4 and IFN-g was normalized by the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Error bars represent means ± SD of the data from three individual mice in each group. Data are representative of three independent experiments (A and C).
Gata3 fl/fl -dLck-Cre cells cultured under Th2 conditions (data not shown). Therefore, the upregulation of Eomes is most likely responsible for IFN-g production in GATA3-deficient ''Th2'' cells.
Eomes, but Not T-bet, Contributes to the IFN-g Production in GATA3-Deficient ''Th2'' Cells Eomes has been reported to play an important role in IFN-g production in CD8 + T cells (Pearce et al., 2003) . In addition, Eomes expression in CD4 + T cells may contribute to optimal IFN-g production by these cells (Suto et al., 2006) . To further address whether Eomes is capable of inducing IFN-g in Th2 cells, WT or Tbx21 À/À CD4 + T cells cultured under Th2 conditions were infected with an Eomes-GFP-Retrovirus (RV). 30.8% of WT and 23.5% of Tbx21 À/À Th2 cells that had been infected with the Eomes-GFP-RV produced IFN-g ( Figure 3A ), whereas less than 1% of control-RV infected Th2 cells produced IFN-g. RV-driven Eomes expression was comparable to endogenous Eomes expression in GATA3-deficient ''Th2'' cells ( Figure S3 ), suggesting Eomes in GATA3-deficient ''Th2'' cells is sufficient to induce IFN-g production independently of T-bet. Interestingly, enforced Eomes expression in Th2 cells did not suppress IL-4 production.
To compare the functions of Eomes and T-bet, expression of mRNA of multiple genes in sorted Th2 cells that had been infected with T-bet-or Eomes-RV was measured by quantitative PCR. Eomes was less potent than T-bet in inducing IFN-g and IL-12Rb2 and in suppressing GATA3 expression, however, it induced CXCR3 to a similar degree as did T-bet ( Figure 3B ). Both T-bet and Eomes are the members of T-box family and they bind to similar DNA sequences. A dominant-negative form of T-bet (T-bet DN) has been reported to suppress the activities of both T-bet and Eomes (Mullen et al., 2002) . Infection of ''Th2'' cells from both Gata3 fl/fl -dLck-Cre and Gata3 fl/fl -dLck-Cre-Tbx21 À/À mice with T-bet DN-GFP-RV reduced the percentage of IFN-g-producing cells by a comparable degree, from 55% to 27% in the former and from 51% to 22% in the latter ( Figure 3C ), indicating that Eomes is at least partially responsible for the capacity of cells lacking GATA3 to produce IFN-g. It also suggests that a non-T-box family member may be responsible for a portion of the IFN-g production.
Runx3 Induces IFN-g Production and Eomes Expression
Runx3 is expressed in Th1 cells and is known to induce the capacity of these cells to produce IFN-g as well as to suppress their production of IL-4 (Djuretic et al., 2007; Naoe et al., 2007) . Because both Runx3 and Eomes are highly expressed in CD8 + T cells (Egawa et al., 2007; Pearce et al., 2003) , we also tested the involvement of Runx3 in IFN-g production by Th2 cells. Runx3-GFP-RV transduction into WT Th2 cells resulted in 41.4% of the cells being able to secrete IFN-g ( Figure 4A , upper panel). The acquisition of IFN-g-producing capacity by overexpression of Runx3 is independent of T-bet since Tbx21 À/À Th2 cells that had been infected with the Runx3-GFP-RV were similar to WT Runx3-GFP-RV-infected cells in their ability to produce IFN-g ( Figure 4A , lower panel). Unlike enforced Eomes expression, Runx3 expression in Th2 cells dramatically reduced the frequency of IL-4-producing cells, from 26% to 3.5% in WT and from 21% to 3.8% in Tbx21 À/À Th2 cells. Thus, the suppression of IL-4-producing capacity by Runx3 is also T-bet-independent.
Interestingly, enforced Runx3 expression strongly induced Eomes mRNA with minimal effects on the expression of T-bet ( Figure 4B ) and GATA3 (data not shown). IFN-g production induced by enforced Runx3 was again partially blocked by T-bet DN ( Figure 4C ), suggesting that Runx3 induces IFN-g production partly through its upregulation of Eomes expression.
Runx3 and T-bet Bind to Multiple Regulatory Elements of the Ifng Gene
To test whether Runx3 is involved in IFN-g production in Th1 cells, we constructed a dominant-negative Runx3 (Runx3 DN) based on a previous report (Hayashi et al., 2000) . Infecting normal Th1 cells with Runx3 DN-RV, similar to that with T-bet DN-RV, dramatically reduced the percentage, as well as the mean fluorescence intensity (MFI), of the IFN-g-producing cells ( Figure 5A ), suggesting optimal IFN-g production in normal Th1 cells requires T-bet, as well as Runx3, function.
To explore the molecular mechanisms underlying these effects, we performed ChIPseq (chromatin immunoprecipitation in combination with high throughput deep sequencing) to identify the binding sites of Runx3 and T-bet in Th1 cells. An antibody to CBFb, which is a cofactor of Runx complexes, was used since we failed to identify ChIP quality Runx3 antibody.
The data showed that Runx protein complex weakly binds to many sites within the Il4-Il13 locus, including DNase I hypersensitivity (HS) IV ( Figure S4A) , the site to which Runx has been previously reported to bind. By contrast, T-bet failed to bind to HS IV, consistent with our data that Runx3-mediated suppression of IL-4 production does not require T-bet. No apparent binding clusters for Runx protein complex can be identified in the vicinity of the Eomes gene ( Figure S4B ), although there are clusters of CBFb binding sites at the Eomes neighbor gene Azi2 (data not shown), suggesting Runx3 may regulate Eomes expression through a long-distance interaction if such action is direct or Runx3 indirectly regulates Eomes.
Importantly, both Runx and T-bet strongly bind to many regulatory elements of the Ifng gene ( Figure 5B ). The common binding sites for these two transcription factors are at conserved noncoding sequence (CNS)À34, CNSÀ22, Ifng promoter (HSI) and CNS+29. In addition, Runx3 uniquely binds to CNS-6, HSII, HSIII and CNS+55, whereas T-bet uniquely binds to CNS+18-20 and CNS+46. These data suggest both Runx3 and T-bet regulate IFN-g production by binding to many critical regulatory elements of the Ifng gene.
GATA3 Represses the Capacity of Runx3 to Induce IFN-g Expression
We have shown here that loss of GATA3 expression in Th2 cells resulted in the acquisition of IFN-g-producing capacity that was correlated with Eomes, but not T-bet expression, and that Runx3 overexpression in Th2 cells resulted in IFN-g-producing capacity and upregulated Eomes. However, the relationship between GATA3 and Runx3 in regulating Eomes and IFN-g expression remains unknown.
We first asked whether it appeared that GATA3 and Runx3 acted in a balanced manner. Th2 cells were coinfected with a Runx3-Thy1.1-RV and a GATA3-GFP-RV. While cells that were infected with neither virus could produce little IFN-g, a substantial proportion of the cells infected with Runx3-RV alone produced IFN-g (23.5%), but this was reversed in cells that had been infected with both the Runx3 and GATA3-RVs (3.5%, Figure 6A ). The amount of IFN-g produced by stimulated doubly-RV-infected cells separated based on the relative intensities of GFP and Thy1.1 expression, representing the relative expression of GATA3 and Runx3, respectively, correlated with the ratio of Runx3 and GATA3 expression ( Figure 6B ). By contrast, an excess of GATA3 did not prevent Runx3 from suppressing IL-4 production. Consistent with its role in regulating IFN-g production, Eomes expression was only enhanced in the cells expressing retroviral Runx3 alone; such induction was repressed by additional GATA3 expression ( Figure 6C) . These results imply that GATA3 suppresses Runx3-mediated Eomes induction and IFN-g production in a quantitative manner.
A possible explanation for such quantitative regulation would be that GATA3 could interact with Runx3 and, thus, block its ability to induce Eomes and IFN-g. Anti-GATA3 immunoprecipitated Runx3 from extracts of primary Th1 cells, indicating an interaction between these two factors ( Figure 7A ). To determine which domains of GATA3 interact with Runx3, we prepared a series of GATA3 mutants ( Figure S5A ). HEK293T cells were singly or cotransfected with expression vectors encoding Runx3 and WT or mutant GATA3. Deletion of the N terminus or zinc fingers of GATA3 abolished its binding to Runx3, whereas a C-terminal deleted GATA3 retained its ability to bind to Runx3 ( Figure 7B ). The GATA3 mutants that failed to interact 
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(A) CD4 + T cells isolated from WT and Tbx21 À/À mice were stimulated under Th2 conditions and infected with Runx3-GFP-RV or Control-GFP-RV. Infected cells were restimulated and stained as in Figure 3A . The dot plots were gated on CD4 + GFP + cells. (B) CD4 + GFP + cells were isolated by cell sorting from the cells prepared in (A). RNAs were prepared from sorted cells, and the expression of Eomes and T-bet was measured by quantitative RT-PCR. The expression levels of each gene in Control-RV infected cells were set as ''1''. (C) CD4 + T cells isolated from WT mice were stimulated under Th2 conditions and then coinfected with Runx3-Thy1.1-RV and T-bet-Eomes DN-GFP-RV or Control-GFP-RV. Infected cells were restimulated and stained as in Figure 3A with Runx3 also lost their capacity to suppress Runx3-mediated IFN-g production in Th2 cells ( Figure 7C ). However, although the GATA3 C-terminal deletion mutant was fully capable of suppressing Runx3-mediated IFN-g production (Figure 7C) , consistent with its ability to bind to Runx3, it had a substantial reduction in its ability to induce IL-4 in Th1 cells ( Figure S5B ).
To confirm that the IFN-g production by GATA3-deficient ''Th2'' cells is Runx3 dependent but T-bet independent, we generated triple-deficient mice, Gata3 fl/fl Runx3 fl/fl -dLck-Cre-Tbx21 À/À ( Figure 7D ). Eomes expression was only slightly reduced in triple-deficient mice, suggesting that there is a Runx3-independent mechanism for Eomes induction when GATA3 is absent in Th2 cells. However, despite continued expression of Eomes, the proportion of IFN-g-producing cells was dramatically reduced in Gata3 fl/fl Runx3 fl/fl -dLck-Cre-Tbx21 À/À ''Th2'' cells compared to Gata3 fl/fl -dLck-Cre-Tbx21 À/À ($8% versus $32%) suggesting that Runx3 is required for the bulk of T-bet-independent IFN-g production in GATA3-deficient ''Th2'' cells and that it is the balance between GATA3 and Runx3 that controls IFN-g production.
DISCUSSION
GATA3 is a crucial transcription factor in the regulation of T helper cell differentiation. Not only is GATA3 critical for inducing Th2 differentiation, but it is also essential for repressing Th1 differentiation. It has been reported that GATA3 represses the IL-12-STAT4-IFN-g pathway during Th2 differentiation through multiple mechanisms, including the suppression of both IL-12Rb2 and STAT4 (Ouyang et al., 1998; Usui et al., 2003) . Here, by using a mouse line carrying a Cre transgene that conditionally deletes Gata3 in naive CD4 + T cells, we demonstrated that GATA3 actively suppresses IFN-g production even in the presence of IL-4, anti-IL-12, and anti-IFN-g. Without GATA3, the expression of STAT4 is increased, but only a modest increase of IL-12Rb2 mRNA expression was noted. IL-12Rb2 expression can be regulated by the IL-12-STAT4 and the IFNg-T-bet pathways (Afkarian et al., 2002; Lawless et al., 2000; Ouyang et al., 1998) . Thus, during Th1 differentiation in the presence of IL-12, the direct target suppressed by enforced GATA3 is likely to be STAT4, and through regulating the IL-12-STAT4 pathway, GATA3 indirectly affects IL-12Rb2, IFN-g, and T-bet expression.
In this report, we describe Runx3-Eomes-mediated IFN-g production in GATA3-deficient ''Th2'' cells. Such IFN-g production is IL-12-STAT4 and IFN-g-T-bet independent. The expression of Eomes, but not T-bet, is enhanced in GATA3-deficient CD4 + T cells cultured under Th2 conditions, where both IL-12 and IFN-g are neutralized. Enforced Eomes expression during Th2 differentiation induces the capacity of these cells to produce IFN-g in the absence of T-bet. Moreover, GATA3 single-deficient and GATA3-T-bet double-deficient CD4 + T cells cultured under Th2 conditions produce similar amount of IFN-g. Such IFN-g production is inhibited by T-bet DN, which has been reported to suppress the function of both T-bet and Eomes (Pearce et al., 2003) . Although the inhibition of IFN-g production by T-bet DN is only partial, the data clearly imply that Eomes, not T-bet, contributes to IFN-g production in GATA3-deficient ''Th2'' cells. We have reported earlier that in Gata3-deleted ''Th2'' clones, T-bet expression was elevated (Zhu et al., 2006) . Because these clones had been cultured for a long period of time, it is possible that the large amount of IFN-g produced by these clones in the culture was not completely neutralized and that IFN-g was responsible for T-bet induction.
Expressing Runx3 in activated CD4 + T cells cultured under Th2 conditions strongly suppresses IL-4 production. Although others have argued that the suppression of IL-4 by Runx3 requires T-bet (Djuretic et al., 2007) , our results clearly demonstrate the suppression of IL-4 by Runx3 is as efficient in T-bet-deficient Th2 cells as in WT cells. In addition, the ChIPseq data show that the Runx protein complex, but not T-bet, binds to the HS IV site of the Il4 locus in Th1 cells. However, T-bet, but not Runx3, suppresses GATA3 expression. Thus, Runx3 and T-bet can collaborate in repressing IL-4 production through two different mechanisms-Runx3 directly suppresses IL-4 and T-bet indirectly affects IL-4 by repressing GATA3.
Besides suppressing IL-4 production, Runx3 induces IFN-g production in Th2 cells correlated with strong induction of Eomes, but not T-bet. Although there is only a slight increase of Runx3 expression when GATA3 is absent, deletion of Runx3 from GATA3-T-bet double-deficient cells results in dramatic decrease in IFN-g production, indicating that Runx3 is needed for IFN-g production in these cells. However, deletion of Runx3 from GATA3-T-bet double-deficient cells only causes a modest decrease in Eomes expression, suggesting Runx3 is redundant for Eomes induction in GATA3-deficient ''Th2'' cells. Furthermore, although Runx3 is highly expressed in Th1 cells, only a small percentage of these cells express Eomes even when GATA3 is deleted, suggesting that Runx3 is not sufficient to induce Eomes expression in a Th1 environment. Whether the Eomes-expressing CD4 + T cells represent a unique lineage of Th cells needs to be further studied. Nevertheless, it has been recently reported that CD8 + T cells, in which GATA3 is underexpressed, have adopted the Runx3-Eomes pathway for their optimal IFN-g production (Cruz-Guilloty et al., 2009) .
Runx3 is highly expressed in Th1 cells and enforced expression of Runx3 DN in Th1 cells results in diminished IFN-g production, consistent with an earlier report that Runx3 regulates IFN-g production (Djuretic et al., 2007) . Here, we show Runx3-mediated IFN-g production can be blocked by GATA3. Furthermore, by using ChIPseq, we show that, in normal Th1 cells, the Runx protein complex binds to multiple critical regulatory elements of Ifng gene, some of which are also bound to T-bet. STAT4 has also been reported to directly bind to the Ifng gene. Therefore, optimal IFN-g production and Th1 differentiation involves three pathways: IL-12-STAT4-, IFN-g-T-bet-, and Runx3-mediated pathways. Each pathway makes some contribution to IFN-g production through direct action on the Ifng gene, and there is also crosstalk among these pathways. For example, STAT4 and T-bet have a synergistic effect on inducing IFN-g production; Runx3 and T-bet can interact with each other and bind to many sites in Ifng locus; T-bet may be responsible for upregulating Runx3 expression; IL-12-STAT4 is partially Figure 3A . The black lines represent CD4 + GFP + cells, and the shaded area represents CD4 + GFP À cells in the same culture. (B) WT Th1 cells were harvested and fixed. ChIPSeq analysis was performed using specific antibody against CBFb or T-bet. The sequence tags mapped to the locus of Ifng are shown. Critical Runx and T-bet binding elements corresponding to DNase I hypersensitivity (HS) sites, and conserved noncoding sequences (CNS) are highlighted. responsible for T-bet upregulation; and T-bet downregulates GATA3 during Th1 differentiation, resulting in the upregulation of STAT4, as well as the release of the inhibition of Runx3mediated IFN-g production. Our finding of GATA3 regulating Runx3 function and STAT4, but not T-bet, expression increases our understanding on the cross-regulation of Th1 versus Th2 differentiation.
We also show that GATA3 physically interacts with Runx3 in primary T cells and the level of IFN-g production strongly correlates with the ratio of Runx3 to GATA3. The N terminus and zinc fingers, but not C terminus, of GATA3 are required for the interaction with Runx3. The GATA3 mutant with the C-terminal deletion substantially loses its ability to induce IL-4, but is fully functional in suppressing Runx3-mediated IFN-g production, suggesting that the positive and negative functions of GATA3 can be separated. This may be critical for guiding effective immune intervention strategies in treating Th1-and Th2-related diseases.
Two reports previously suggest that the association of transcription factors dominant in different Th lineages can mutually Figure 6 . GATA3 Represses Runx3-Mediated IFN-g Production and Eomes Induction (A and B) WT CD4 + T cells were stimulated under Th2 conditions and coinfected with GATA3-GFP-RV and Runx3-Thy1.1-RV. Infected cells were restimulated and stained as in Figure 3A . The dot plots were gated based on the expression of GFP and Thy1.1 (A). Nine subsets (1 through 9) expressing different amount of GFP and Thy1.1 were selected for further analysis (B, left panel) . The percentages of IL-4 or IFN-g-producing cells from these nine subsets were plotted (B, right panel). (C) WT CD4 + T cells were stimulated and infected as in (A). Infected cells were sorted based on the expression of GFP and Thy1.1. RNAs were prepared from sorted cells, and the expression of Eomes was measured by quantitative RT-PCR. The relative expression of Eomes in Control-Thy1.1 + and Control-GFP + cells was set as ''1''. Error bars represent means ± SD. Data are representative of three (A and B) and two (C) independent experiments.
regulate their functions (i.e., T-bet and GATA3; Foxp3 and RORgt) (Hwang et al., 2005; Zhou et al., 2008) . Here, we reported a third example of such mutual regulation between GATA3 and Runx3 during Th1-Th2 differentiation. Since both GATA3 and Runx3 are also critical during CD4 versus CD8 lineage commitment in thymus (Bosselut, 2004; Herná ndez-Hoyos et al., 2003; Pai et al., 2003; Sato et al., 2005; Setoguchi et al., 2008; Taniuchi et al., 2002) , the interaction and cross-regulation of these two molecules may also play a role in determining CD4-CD8 fate in the thymus, a subject that needs to be further studied.
In conclusion, we show that Runx3 directly bound to many critical regulatory elements at the Ifng locus and induced IFN-g expression even in the absence of T-bet. GATA3 suppressed Runx3-mediated IFN-g production through protein-protein interactions. Therefore, the relative amount of GATA3 and Runx3 expression plays a role in regulating Th1 versus Th2 responses.
EXPERIMENTAL PROCEDURES Animals
Mice carrying dLck-Cre transgene (line 3779), Runx3 fl/fl mice, and Gata3 fl/fl mice were previously reported Zhang et al., 2005; Zhu et al., 2004) . Tbx21 À/À mice (line 4648) were obtained from the Jackson laboratory (Finotto et al., 2002) . All mice were bred and maintained under specific pathogen-free conditions in the National Institute of Allergy and Infectious Diseases (NIAID) animal facility and used at 5-12 weeks of age under an approved protocol according to the NIAID guidelines for animal care.
Preparation of Cells
CD4 + T cells were isolated from lymph nodes by negative selection as previously described (Yamane et al., 2005) , except when autoMACS (Miltenyi Biotec) was used. For purification of naive CD4 + T cells, CD44 lo CD62L hi CD4 + T cells were sorted by FACSAria (BD Biosciences). T cell-depleted splenocytes were prepared by incubation with anti-Thy1.2 mAb supernatant and rabbit complement (Cedarlane Laboratories Limited) at 37 C for 45 min, followed by irradiation at 30 Gy (3,000 rad). In some experiments, mice were injected subcutaneously with 500 third-stage infectious larvae of N. brasiliensis . On day 9 after N. brasiliensis infection, CD4 + CD44 hi CD62L lo T cells from mesenteric lymph nodes were sorted by FACSAria.
Activation of T Cells
CD4 + T cells were cultured with irradiated T cell-depleted splenocytes in the presence of 1 mg/ml of anti-CD3 (145-2C11) and 3 mg/ml of anti-CD28 (37.51) for 3 days with various combinations of antibodies and cytokines: for Th1 conditions, 10 ng/ml of IL-12 and 10 mg/ml anti-IL-4 (11B11); for Th2 conditions, 5000 U/ml of IL-4, 10 mg/ml anti-IL-12 (C17.8) and anti-IFN-g (XMG1.2); and for ThNeutral conditions, no additional cytokines or antibodies added. The activated cells were then cultured in IL-2 (50 U/ml)-containing medium.
Retroviral Constructs and Infection
Eomes-GFP-RV and T-bet DN-GFP-RV constructs were previously described (Pearce et al., 2003) . Runx3 and Gata3 cDNA were cloned from Th1 and Th2 cells, respectively, by PCR. The details for the construction of the Runx3-RV, GATA3-RV, Runx3 DN-RV, and mutant GATA3-RV are described in Supplemental Experimental Procedures. Retroviruses were prepared by transfecting Phoenix-Eco packaging cell line with RV constructs using Fugene6 (Roche) as previously described and were concentrated from the culture supernatant by centrifugation at 12,000 g for 14-18 hr at 4 C. CD4 + T cells were stimulated with T cell-depleted splenocytes for 24 hr in the presence of anti-CD3 and anti-CD28 mAbs under Th1 or Th2 conditions and then infected with concentrated RV as previously described . In some experiments, on day 4, RV-infected cells were sorted based on the expression of GFP and/or Thy1.1.
RNA Purification and Quantitative PCR
Total RNAs were isolated using a combination of TRIzol (Invitrogen) and RNeasy Kit (QIAGEN). cDNAs were prepared using SuperScript III Reverse Transcriptase (Invitrogen). Quantitative PCR was performed on a 7900HT Sequence Detection System (Applied Biosystems) using the following predesigned primer-probe sets: IL-4, IFN-g Eomes, T-bet, STAT4, IL-12Rb2, CXCR3, and GAPDH (all purchased from Applied Biosystems) and GATA3, as previously described . Primers and probe for detecting Figure 7 . Runx3 Protein Interacts with GATA3 Protein, and Runx3 is Responsible for IFN-g Production in GATA3-Deficient ''Th2'' Cells (A) Total Th1 cell lysates were immunoprecipitated with anti-GATA3 or isotype antibody and then immunoblotted with anti-Runx polyclonal Ab. The membrane was then stripped and reblotted with GATA3 mAb. The cell lysates passed the IP columns were also blotted with anti-Runx as a loading control. (B) Runx3-RV and Myc-tagged WT or mutant GATA3-RV were cotransfected into HEK293T cells as indicated. Total cell lysates or anti-GATA3-immunoprecipitated cell lysates were blotted with anti-Runx or anti-Myc. (C) WT CD4 + T cells were stimulated under Th2 conditions and coinfected with Runx3-GFP-RV and WT or mutant GATA3-Thy1.1-RV. Infected cells were restimulated and stained as in Figure 3A . The percentage of IFN-g-producing cells in each CD4 + GFP + group was plotted. (D) CD4 + T cells isolated from WT, Gata3 fl/fl -dLck-Cre-Tbx21 À/À , or Gata3 fl/fl Runx3 fl/fl dLck-Cre-Tbx21 À/À mice were activated under Th2 conditions as shown in Figure 1A . They were then stained for intracellular IL-4, IFN-g, and Eomes expression. Numbers indicate the percentage in each quadrant. Data are representative of two independent experiments. distal Runx3 are as follows: 5 0 -TCCAACAGCATCTTTGACTCCTT-3 0 , 5 0 -GGTG CTCGGGTCTCGTATGA-3 0 , and 5 0 -FAM-CCCAACTATACACCAACC-MGB-3 0 . The efficiency of Gata3 deletion was determined by quantitative PCR, as previously described .
Intracellular Staining
Intracellular staining was performed as previously described . In brief, the activated cells maintained in IL-2-containing medium for 1-3 days were restimulated with 10 ng/ml phorbol 12-myristate 13-acetate (PMA) and 500 nM ionomycin in the presence of 2 mM monensin for 4 hr. At the end of stimulation, cells were stained with anti-CD4 and anti-Thy1.1, washed and fixed with 4% paraformaldehyde for 10 min at room temperature, and permeabilized in PBS containing 0.5% Triton X-100 and 0.1% BSA. They were then stained for cytokines and analyzed by FACSCalibur or LSR II (BD Biosciences), and results were analyzed using FlowJo software (Tree Star). Staining of the transcription factors was carried out with Foxp3 Staining Buffer Set (eBioscience) according to the manufacturer's instructions. Anti-GATA3 (L50-823), anti-T-bet (4B10), and anti-Eomes (Dan11mag) were purchased from BD Biosciences and e-Biosciences, respectively. ChIPseq Analysis 5 3 10 6 cells CD4 + T cells that have been cultured under Th1 conditions for two rounds, with each round consisting of 4 day TCR stimulation and 2 day culture in IL-2-containing medium, were cross-linked with formaldehyde, and the chromatin was sonicated into small fragments. Then the fragmented chromatin was immunoprecipitated with specific antibodies. Anti-CBFb was kindly provided by Dr. I. Taniuchi. T-bet antibody (4B10) was purchased from Santa Cruz. The ChIP DNA fragments with a size of $200 bp were treated and sequenced using the Illumina-Solexa 1G Genome Analyzer, as previously described (Barski et al., 2007) . Sequence reads originating in 200 bp windows were summed and displayed as custom tracks on the UCSC Genome Browser.
Immunoprecipitation and Immunoblotting CD4 + T cells activated under Th1 or Th2 conditions for 4 to 5 days were used for immunoprecipitation and/or immunoblotting. In some experiments, RV constructs containing Runx3, WT, and mutant GATA3 cDNAs were transfected into HEK293T cells using Fugene6, and these cells were harvested 2 days after transfection. The details of immunoprecipitation and immunoblotting are described in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
The Supplemental Information includes five figures and Supplemental Experimental Procedures and can be found with this article online at doi:10.1016/j. immuni.2010.04.004.
